More Monitoring Required of Institutional Review Boards
The Government Accountability Office has issued an analysis suggesting that the FDA should increase its oversight of institutional review boards (IRBs) to better protect...
Stroke Patients To Get A Relief With Spinal Cord Stimulation
A small clinical trial has suggested that spinal cord stimulation may help stroke patients regain movement in their limbs and hands. In an article...
Major Trial Reveals Simplified HIV Treatment Options Perfect
As per the results of international research, which has the distinction of being the world’s first study into second-line human immunodeficiency virus- HIV therapy,...
DNA Mutations Can Help Kidney Cancer Recurrence Be Assessed
One of the international studies on kidney cancer recurrence has found that physicians can forecast the likelihood of a disease returning by way of...
Terminal Sterilisation Process For Oligonucleotide Drugs
There is a new report which has gone on to review the processing of the present state of sterile oligonucleotide drug product. This includes...
New Initiatives To Boost Biomanufacturing In South Australia
Biomanufacturing industry is all set to get the much-needed push by the recent South Australian Government’s announcement when it comes to new initiatives as...
Research Says Fight Against Cancer Gets A Boost With STAT5
STAT5 has long been regarded as an interesting target versus cancer, but after several decades of research, it was relegated to the undruggable category....
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...